Cochrane Abstracts
Antifibrinolytics for heavy menstrual bleeding
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antifibrinolytics for Heavy Menstrual Bleeding." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431702/all/Antifibrinolytics_for_heavy_menstrual_bleeding.
Antifibrinolytics for heavy menstrual bleeding. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431702/all/Antifibrinolytics_for_heavy_menstrual_bleeding. Accessed December 11, 2024.
Antifibrinolytics for heavy menstrual bleeding. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431702/all/Antifibrinolytics_for_heavy_menstrual_bleeding
Antifibrinolytics for Heavy Menstrual Bleeding [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431702/all/Antifibrinolytics_for_heavy_menstrual_bleeding.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antifibrinolytics for heavy menstrual bleeding
ID - 431702
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431702/all/Antifibrinolytics_for_heavy_menstrual_bleeding
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
